Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review

Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review

Infections due to carbapenem-resistant Enterobacterales (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes, especially in critically ill patients. Novel beta lactam antibiotics, including ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, i...

Full description

Bibliographic Details
Main Authors: Francesco Venuti, Lorenza Romani, Maia De Luca, Costanza Tripiciano, Paolo Palma, Maria Chiriaco, Andrea Finocchi, Laura Lancella
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Microorganisms
Subjects:
children
pediatric
multidrug resistant
Gram-negative bacteria
infections
ceftolozane/tazobactam
Online Access:https://www.mdpi.com/2076-2607/11/7/1798

Internet

https://www.mdpi.com/2076-2607/11/7/1798

Similar Items